about the Summit
The UNITE Global Summit is the world’s leading Forum for forging partnerships between parliamentarians and leaders from the global health community. Leading parliamentarians from across the world will gather with experts from civil society, affected communities, international organizations and academia to discuss the most pressing issues in Global Health and set the political agenda for the year(s) to come.
- Human Rights & Equitable Access to Health
- Global Health Architecture & Security
- Strengthening of Healthcare Systems
- Sustainable Financing for Health
Ultimately, we are seeking to answer two main questions:
- What can parliamentarians do to turn science into evidence-based policy?
- What do parliamentarians need from the global health community to achieve this goal?
Opening Dinner
UNITE Global Summit 2024
collaboration with the World Health Summit
In 2024, the World Health Summit and the UNITE Global Summit will join efforts and partner for an additional conference day, in Berlin, with the aim of placing global health at the highest level of the political agenda.
The World Health Summit and UNITE intend to catalyze exchanges between parliamentarians and relevant stakeholders in global health, better aligning policymaking with the main discussions, outcomes and recommendations resulting from WHS 2024.
the agenda
The UNITE Global Summit 2024’s agenda will be divided into four main pillars which cover relevant global health topics of the hour:
Human Rights & Equitable Access to Health
Global Health Architecture & Security
Strengthening of Healthcare Systems
Sustainable Financing for Health
08:00 - 09:00
Não
---
Opening of Registration Desk
Opening of Registration Desk
Speakers & Participants
09:00 - 09:45
Não
Opening Session
Building Trust for Global Health in an era of Political, Social and Health Challenges
Today, global health faces unprecedented challenges due to different but convergent political, social, economic, and environmental factors. These questions include political polarization, disinformation and misinformation, especially […]
Building Trust for Global Health in an era of Political, Social and Health Challenges
Today, global health faces unprecedented challenges due to different but convergent political, social, economic, and environmental factors. These questions include political polarization, disinformation and misinformation, especially on social media, climate change and conflict, that lead to the increase of migration flows, and economic inequalities within and between countries.
Besides these global challenges, the COVID-19 pandemic and the perception that health institutions were not prepared to face it have deeply eroded trust in institutions, including healthcare systems.
This erosion of trust weakens public health initiatives and raises doubts about the efforts needed to tackle global health crises and achieve health for all. Members of Parliament, as representatives of different sectors of society, play a critical role in rebuilding trust both in health and political institutions.
Speakers & Participants
Human Rights & Equitable Access to Health
09:45 - 10:00
Não
Keynote Speech
Engaging Patients in Universal Health Coverage (UHC) – A Path Towards Equity
Engaging Patients in Universal Health Coverage (UHC) – A Path Towards Equity
Speakers & Participants
Human Rights & Equitable Access to Health
10:00 - 11:15
Parallel Session
Parliamentary Inquiry
Implementing a Human Rights Framework in Drug Policies
In recent years, the global community and international organizations have placed an increasing focus on the human rights impacts of drug policies. Drug control efforts seriously […]
Implementing a Human Rights Framework in Drug Policies
In recent years, the global community and international organizations have placed an increasing focus on the human rights impacts of drug policies. Drug control efforts seriously undermine human rights in many countries, emphasizing the need for a new approach to drug policy at the global, regional and national levels.
While evidence and guidance from international organizations has long recommended shifting the focus of drug policies from law enforcement to public health approaches, many jurisdictions continue to enforce criminal sanctions on people who use drugs. The criminalization of drug use has exacerbated stigma and discrimination and hindered access to critical health and harm reduction services for people who use drugs; and global drug enforcement continues to have a detrimental impact on the enjoyment of human rights by all.
In this Parliamentary Inquiry, case studies of drug policy reform initiatives will be presented, focusing on opportunities and challenges of implementation at the national, regional and international levels. Expert speakers and participants will highlight how change is possible and what it means to implement a human rights framework in drug policies on the ground, sharing important lessons learned and practical steps parliamentarians take to inform and advance efforts across countries and levels of governance.
Speakers & Participants
Human Rights & Equitable Access to Health
10:00 - 11:15
Parallel Session
Parliamentary Inquiry
Elevating Patient Perspectives in Universal Health Coverage (UHC): A Focus on Liver Cancer
Universal Health Coverage (UHC) is crucial for improving global health, yet patient perspectives are often overlooked. Engaging patient groups is essential to address health disparities and […]
Elevating Patient Perspectives in Universal Health Coverage (UHC): A Focus on Liver Cancer
Universal Health Coverage (UHC) is crucial for improving global health, yet patient perspectives are often overlooked. Engaging patient groups is essential to address health disparities and ensure that policies reflect the needs of all populations, particularly for liver cancer, where early diagnosis and equitable access are critical. This inquiry will provide a platform for parliamentarians to discuss how patient inclusion and preventive measures—such as vaccinations, public health campaigns, and early detection—can improve outcomes for liver cancer patients.
Liver cancer is frequently diagnosed too late, partly due to limited access to early detection tools and stigma linked to lifestyle factors or infectious diseases like hepatitis. This session will explore policies to reduce stigma, promote patient participation in UHC, and create an inclusive, rights-based healthcare system that prioritizes equitable access to care for all.
Speakers & Participants
11:30 - 11:45
Não
---
Welcome Words by Hon. Yvonne Magwas, Vice-President of the German Bundestag
Welcome Words by Hon. Yvonne Magwas, Vice-President of the German Bundestag
Speakers & Participants
Global Health Architecture & Security
11:45 - 12:00
Não
Keynote Speech
Building Resilience: Strengthening Global Health Architecture for a Secure Future
The urgent need for a more robust global health system has become increasingly clear in the face of emerging threats. Strengthening health architecture involves fostering international […]
Building Resilience: Strengthening Global Health Architecture for a Secure Future
The urgent need for a more robust global health system has become increasingly clear in the face of emerging threats. Strengthening health architecture involves fostering international collaboration, investing in resilient infrastructure, and integrating innovative technologies. Comprehensive health security measures are crucial for enhancing preparedness and response capabilities.
A global pandemic agreement is essential to ensure coordinated responses and equitable distribution of resources during health crises. Equitable access to healthcare is essential for ensuring sustainable health outcomes, enabling communities worldwide to effectively navigate future challenges and protect public health.
Speakers & Participants
Global Health Architecture & Security
12:00 - 13:15
Parallel Session
Parliamentary Inquiry
A Dual Threat to Global Health: Combating Antimicrobial Resistance and Sepsis Through Unified Action
Antimicrobial resistance (AMR) poses a growing threat to healthcare, endangering critical treatments like surgeries, cancer care, and safe childbirth. AMR already causes over 1.27 million deaths […]
A Dual Threat to Global Health: Combating Antimicrobial Resistance and Sepsis Through Unified Action
Antimicrobial resistance (AMR) poses a growing threat to healthcare, endangering critical treatments like surgeries, cancer care, and safe childbirth. AMR already causes over 1.27 million deaths annually, contributing to nearly 5 million more. Addressing this requires urgent action, including sustainable funding, better access to antibiotics, and investment in research and development (R&D). Without these measures, progress in healthcare could be reversed.
Sepsis, closely tied to AMR, is responsible for nearly 14 million deaths each year but remains under-prioritized globally. The 2030 Global Agenda for Sepsis, supported by UNITE and other global partners, calls for a coordinated response to combat both AMR and sepsis. This inquiry will explore policies that integrate efforts to address these twin threats, ensuring stronger health systems and better global health outcomes.
Speakers & Participants
Global Health Architecture & Security
12:00 - 13:15
Parallel Session
Parliamentary Inquiry
Towards a Safer Tomorrow: the Role of Parliamentarians in Advocating for a Global Pandemic Agreement
Towards a Safer Tomorrow: the Role of Parliamentarians in Advocating for a Global Pandemic Agreement
Speakers & Participants
Strengthening of Healthcare Systems
14:45 - 15:00
Não
Keynote Speech
Enhancing Africa’s Response to NCDs: The Role of the Private Sector in Strengthening Health Systems
Many countries are now tasked with strengthening their healthcare systems and Non-Communicable Diseases (NCDs) have emerged as the primary cause of premature death and disability, affecting […]
Enhancing Africa’s Response to NCDs: The Role of the Private Sector in Strengthening Health Systems
Many countries are now tasked with strengthening their healthcare systems and Non-Communicable Diseases (NCDs) have emerged as the primary cause of premature death and disability, affecting both industrialized and Low- and Middle-Income Countries (LMICs). Conditions such as cardiovascular diseases, cancer, diabetes, chronic respiratory conditions, and mental health disorders are increasing in prevalence, posing significant challenges for healthcare systems globally.
Addressing these challenges requires collaborative efforts to enhance regulatory frameworks, procurement processes and supply chains, to train healthcare professionals, to improve diagnostic and data capabilities, as well as to increase funding for NCDs management.
Research-based pharmaceutical companies are eager to expand existing collaborations with governments and other healthcare system’s stakeholders to improve outcomes for those living with NCDs. Collaborative examples such as “Access Accelerated”, the Ghana Heart Initiative (now called AYA), and many other public-private partnerships listed by the Global Health Progress and the WHO Knowledge Action Portal on NCDs, demonstrate the breadth and impact of these partnerships.
Strong collaboration, additional investments, and accelerated implementation of NCDs programs are crucial for achieving the health-related Sustainable Development Goals.
Speakers & Participants
Strengthening of Healthcare Systems
15:00 - 16:15
Parallel Session
Parliamentary Inquiry
Trust, Tech, and Equity: Strengthening Legislative Frameworks to Responsibly Govern Data, AI, and Innovation for Health
Digital health transformation has become an intrinsic part of revolutionizing health systems to achieve Universal Health Coverage (UHC) goals. Health data is a vital asset and […]
Trust, Tech, and Equity: Strengthening Legislative Frameworks to Responsibly Govern Data, AI, and Innovation for Health
Digital health transformation has become an intrinsic part of revolutionizing health systems to achieve Universal Health Coverage (UHC) goals. Health data is a vital asset and the foundation of 21st century health systems, enabling AI; supporting healthcare professionals; strengthening equitable and resilient health systems; improving health emergency and pandemic response; empowering individuals to achieve their personal health goals; and ultimately enhancing healthcare delivery and outcomes, towards UHC goals. AI in the health sector, both for development of tools and use should be guided by ethical considerations which are aligned with human rights.Without strong political leadership, progress remains an elusive goal.
Robust legislative and governance framework must, therefore, accompany this rampant innovation to ensure that digital health interventions and AI are used safely, equitably, ethically and with transparency and ensure digital health transformation is equitable, inclusive, rights-based and sustainable. Parliamentarians are uniquely positioned to support this and to propel governments to strengthen legislative and regulatory frameworks for digital health and health data governance; and will lay a significant role in balancing related regulatory frameworks to govern the use of AI in health and translate the global principles and guidelines into their national-level health policies and regulatory systems.
This Parliamentary Inquiry aims to understand the opportunity brought by digital health, including AI and health data and what is needed to mitigate risks and build trust to harness their use to strengthen health systems, equity and outcomes. It will also delve deeper into opportunities to advance towards more robust data governance approaches, with a focus on legislative and governance aspects, and comprehend the potential of AI in health and role of different stakeholders in AI governance to strengthen health systems and ensure progress towards UHC wider health goals.
Speakers & Participants
Strengthening of Healthcare Systems
15:00 - 16:15
Parallel Session
Parliamentary Inquiry
Strengthening Health Systems to Combat NCDs in Africa: the Role of the Private Sector
Non-communicable diseases (NCDs) pose a significant and growing challenge in Africa, accounting for an increasing burden of morbidity and mortality. Conditions such as cardiovascular diseases, diabetes, […]
Strengthening Health Systems to Combat NCDs in Africa: the Role of the Private Sector
Non-communicable diseases (NCDs) pose a significant and growing challenge in Africa, accounting for an increasing burden of morbidity and mortality. Conditions such as cardiovascular diseases, diabetes, cancer, and respiratory illnesses are exacerbated by factors like urbanization, lifestyle changes, limited healthcare infrastructure, and a lack of awareness and early detection programs. The private sector plays a critical role in addressing these challenges by fostering public-private partnerships, investing in healthcare infrastructure, and promoting access to affordable medicines and technologies. Additionally, private companies can contribute through corporate social responsibility initiatives that support health education, preventive care programs, and innovative solutions to strengthen health systems, ultimately improving the capacity to combat NCDs across the continent.
Indeed, building durable multisectoral coalitions of legislators, civil society, academics, the private sector and other parts of government, have been seen to be a major contributing factor in countries where more resources are being devoted to NCDs and mental health, such as in Chile or the Philippines.
Members of Parliament also play a vital role by advocating for stronger health policies, ensuring budget allocations for NCD prevention and treatment, and creating an enabling regulatory environment that encourages private sector involvement in addressing these health issues.
Speakers & Participants
Sustainable Financing for Health
16:30 - 16:45
Não
Keynote Speech
The Role of MPs in Preventing Health-related Poverty: a Conversation with Dr Madga Robalo, UHC2030 Co-Chair
According to the World Health Organization, at least 4.5 billion people — more than half of the world’s population — lack essential health services. Financial protection […]
The Role of MPs in Preventing Health-related Poverty: a Conversation with Dr Madga Robalo, UHC2030 Co-Chair
According to the World Health Organization, at least 4.5 billion people — more than half of the world’s population — lack essential health services. Financial protection has progressively deteriorated over the last 20 years, with 2 billion people experiencing financial hardship due to out-of-pocket health costs. For many, these payments lead to what is known as a ‘catastrophic cost,’ forcing individuals to forgo or delay necessary medical care. This not only prolongs illness but can also have long-term, devastating effects on health, income, and livelihoods. The consequences of this situation extend beyond individuals and families to affect governments and societies at large. As more people face health crises, nations lose valuable human capital, while long-term care and welfare support costs rise. Moreover, these avoidable health-related expenditures contribute to higher national healthcare costs, placing even greater pressure on public systems.
As elected representatives, Members of Parliament hold a pivotal role in addressing these challenges. Countries must translate their commitments to universal health coverage (UHC) into concrete laws, budgets, policies, and programmes aimed at reducing financial barriers to essential health services, particularly for the poorest and most vulnerable populations. Reducing financial barriers to healthcare and protecting people from the financial hardship that often accompanies illness must be priorities. Lawmakers must drive the legislative and policy reforms needed to ensure that all citizens, especially those in vulnerable and marginalized communities, have access to affordable, quality health services.
Speakers & Participants
Sustainable Financing for Health
16:45 - 18:00
Parallel Session
Parliamentary Inquiry
Sustaining Immunization and Health Equity: The Role of Parliamentarians in Financing Vaccine Access and Resilience
Gavi, the Vaccine Alliance, has successfully immunized over 1 billion children in low- and middle-income countries, significantly reducing vaccine- preventable diseases. As a global public-private partnership, […]
Sustaining Immunization and Health Equity: The Role of Parliamentarians in Financing Vaccine Access and Resilience
Gavi, the Vaccine Alliance, has successfully immunized over 1 billion children in low- and middle-income countries, significantly reducing vaccine- preventable diseases. As a global public-private partnership, Gavi emphasizes the critical need for sustainable investments in immunization, calling on parliamentarians to play a pivotal role in maintaining and scaling these efforts.
At the UNITE Global Summit, Gavi highlights the importance of strengthening health systems and enhancing local vaccine production capacity. By prioritizing immunization in public policies and budgets, parliamentarians can help ensure equitable vaccine access and build resilience against future pandemics, ultimately contributing to global health security.
Speakers & Participants
Sustainable Financing for Health
16:45 - 18:00
Parallel Session
Parliamentary Inquiry
Sustaining Progress and Advocacy in the Fight Against HIV: a Roadmap to 2030 and Beyond
Since the 1980s, the HIV/AIDS epidemic has shifted from a global health crisis to a manageable condition, thanks to antiretroviral therapy (ART) and global initiatives like […]
Sustaining Progress and Advocacy in the Fight Against HIV: a Roadmap to 2030 and Beyond
Since the 1980s, the HIV/AIDS epidemic has shifted from a global health crisis to a manageable condition, thanks to antiretroviral therapy (ART) and global initiatives like UNAIDS’ 90-90-90 targets. Despite these advances, barriers to universal access and ongoing stigma continue to hinder progress, particularly in marginalized communities.
Looking beyond 2030, advocacy will be key to sustaining progress, addressing inequalities, and ensuring HIV remains a priority. Efforts will focus on combating stigma, securing equitable treatment access, and integrating HIV into broader health systems while maintaining global attention and funding.
Speakers & Participants
18:00 - 18:30
Não
Closing Session
Post-Sustainable Development Goals (SDGs): Charting the Future of Global Health
As the UNITE Global Summit 2024 concludes, it is imperative to reflect on the trajectory beyond the Sustainable Development Goals (SDGs) and the future of global […]
Post-Sustainable Development Goals (SDGs): Charting the Future of Global Health
As the UNITE Global Summit 2024 concludes, it is imperative to reflect on the trajectory beyond the Sustainable Development Goals (SDGs) and the future of global health. The SDGs have provided a valuable framework for fostering sustainable development and addressing critical issues such as poverty, inequality, and health. However, as we approach the 2030 deadline, we must acknowledge that the end of the SDG era marks not a conclusion but a new beginning, one that demands renewed commitment and innovative approaches to emerging challenges.
Speakers & Participants
Become a sponsor of the UNITE Global Summit
host
Dr. Eleanor Nwadinobi, M.D.
She is the first Nigerian to rise to the position of International President of the Medical Women's International Association (MWIA) in its over one - hundred year existence. She sits on the boards of several National and International Organisations including Every Woman Treaty, a coalition advocating for an optional protocol to end all forms of violence against women and girls and is Co-chair Immunization Agenda (IA) 2030 Partnership Council.
Eleanor has authored several publications and received numerous awards of merit.
Dr. Eleanor Nwadinobi, M.D.
President, Medical Women's International Association (MWIA)
Dr. Branwen J Hennig, PhD
Previously, Branwen consulted for TDR at the World Health Organization (WHO) on implementation research in low-resource settings. As the Interim Head of International Operations at Wellcome in London, UK, she oversaw Wellcome’s Africa & Asia Programmes.
Branwen’s expertise as global health specialist covers the spectrum from research & development through to translation into policy & practice. Her experience builds on developing and delivering strategic priorities in global health as funder and consultant, and leading research at the MRC Unit The Gambia / London School of Hygiene & Tropical Medicine and beyond.
Dr. Branwen J Hennig, PhD
Executive Director, Global Health Policy Lab
speakers & participants
Dr. Ricardo Baptista Leite, M.D.
President & Founder, UNITE, Portugal
Dr. Ricardo Baptista Leite, M.D.
• Chief Executive Officer (CEO) of HealthAI – The Global Agency for Responsible AI in Health, a Geneva-based organization striving to enable and improve access to inclusive, impactful and responsible regulation in the areas of Digital and Artificial Intelligence (AI) with focus on healthcare.
• Global Ambassador of the ‘G20 Health & Development Partnership’ aimed at advising and advocating G20 countries on health policies aligned with the UN Sustainable Development Goals.
• Chair of the Center for Global Health at NOVA Information Management School (NOVA IMS)
• Founder of CREATING HEALTH – Research and Innovation funding, a sustainable nonprofit which has been set up within the Católica University of Portugal to help capture funding for health innovation and research projects (http://creatinghealth.ics.lisboa.ucp.pt).
Prof. José Manuel Barroso
Board Chair at Gavi, The Vaccine Alliance
Prof. José Manuel Barroso
He was Prime Minister of Portugal (2002-2004) and President of the European Commission for two terms (2004-2009 and 2009-2014).
He is also President of the General Assembly of the Portuguese Diaspora Council and Chairman of its EurAfrican Forum.
In his long political career, José Manuel Barroso held governmental functions for twelve years (Secretary of State for Internal Administration, Secretary of State for Foreign Affairs and Cooperation, Minister of Foreign Affairs, and Prime Minister) and also party functions, namely President of the Social Democratic Party, and parliamentary positions (Chairman of the Committee on Foreign Affairs of the Assembly of the Republic).
In the academic field, he holds a master's degree in Law (University of Lisbon) and a master's degree in Economic and Social Sciences - Political Sciences as well as a master's degree in European Studies (University of Geneva).
Hon. Yvonne Magwas
Vice-President, German Bundestag
Hon. Yvonne Magwas
She worked as a research associate, advisor and office manager at the German Bundestag from 2005 to 2013. In 2013, Magwas was elected to the German Bundestag, where she served as Chairwoman of the Women's Group within the CDU/CSU parliamentary group and as a member of the Committee on Cultural and Media Affairs; on the Environment; Building and Nuclear Safety; on Education, Research and Technology Assessment and the Budget Committee. Magwas currently serves as Vice President of the German Bundestag.
She is also Deputy Federal Chairwoman of the CDU's Women's Union and a member of the Konrad Adenauer Foundation. She is Catholic and has one child.
Dr. Catharina Boehme
Assistant Director-General, External Relations and Governance, World Health Organization
Dr. Catharina Boehme
Her portfolio includes providing secretariat support for the World Health Assembly and the WHO Executive Board, along with intergovernmental processes mandated by WHO governing bodies, including those that relate to governance reform and sustainable financing. She oversees WHO’s coordinated resource mobilization and donor relations and Organization-wide efforts to improve the predictability, flexibility and sustainability of WHO financing.
Dr Boehme is also responsible for engaging WHO in multilateral and multisectoral partnerships for advancing global health, including with civil society, the private sector and other non-state actors.
From 2021-2023, Dr Boehme served as the Director-General’s Chef de Cabinet. In this role, she drove the leadership’s strategic vision, ensuring alignment across the Organization and with Member States and partners. Prior to assuming this role, Dr Boehme was the Chief Executive Officer of FIND, the international alliance for diagnostics, for 8 years. Under her leadership, the Organization improved access to diagnosis for more than 100 million people in low- and middle-income countries and tackled major emerging challenges such as antimicrobial resistance, infectious disease outbreaks and noncommunicable diseases. She was co-convener of the Access to COVID-19 Tools Accelerator to drive equitable access to COVID-19 testing.
Early in her career, Dr Boehme worked in Ghana and the United Republic of Tanzania, focusing on clinical research to eliminate tuberculosis. She has served on several WHO and global advisory bodies, participated in two Lancet Commissions and published in several hundred peer-reviewed publications. Dr Boehme trained as a medical doctor and has diplomas in public health and management.
Prof. Dr. Axel Pries
President, World Health Summit
Prof. Dr. Axel Pries
He was general secretary of the European Society for Microcirculation (ESM) and chair of the International Liaison Committee for Microcirculation. His awards include the Malpighi Award of the ESM, the Poiseuille Gold Medal of the International Society of Biorheology and the Silver Medal of the ESC.
2015 to 2022 he was Dean of Charité - Universitätsmedizin Berlin and served from 2018 to 2020 as interim CEO of the Berlin Institute of Health (BIH) and as President of the Biomedical Alliance in Europe. 2021, he became President of the World Health Summit. Since 2023 he is also Prorector of the Danube Private University in Krems / Austria.
Peter Sands
Executive Director, The Global Fund to Fight AIDS, Tuberculosis and Malaria
Peter Sands
Peter was Group CEO of Standard Chartered PLC from November 2006 to June 2015, having joined the Board of Standard Chartered as Group CFO in May 2002.
Prior to joining Standard Chartered, Peter was a Senior Partner at McKinsey & Co. Peter has served on various boards and commissions, including the UK’s Department of Health, the World Economic Forum and the International Advisory Board of the Monetary Authority of Singapore. He is currently Chair of the Board of Cera, a digital-first home healthcare company based in the UK.
Peter graduated from Oxford University with a First Class degree in Politics, Philosophy and Economics. He also received a Master in Public Administration from Harvard University, where he was a Harkness Fellow. Peter, who grew up in Singapore and Malaysia, is married to author Betsy Tobin and has four children.
Dr. Faustine Ndugulile
Member of Parliament, Tanzania
Dr. Faustine Ndugulile
Dr. Huma Abbasi
General Manager Health & Medical, Chevron
Dr. Huma Abbasi
She began her career at Chevron in a lead role in Occupational Health and has successfully managed Americas, Europe, Eurasia, Middle East and Africa regional medical portfolios, management and development of the H&M Center of Excellence (COE), leading the deployment and implementation of Operational Excellence Management System and working in central advisory and regional positions in the U.S., Asia Pacific, Africa, Middle East and Pakistan regions.
She also facilitated the development and implementation of Health, Environment and Safety Programs and developed tools and processes to help regions attain superior performance. She has worked in many countries around the globe on prevention and treatment of infectious diseases with a focus on tuberculosis, hepatitis and HIV/AIDS.
She completed her degree in Medicine from University of Karachi, has a Fellowship in Specialized Pathology & Hematology and Master’s in Public Health from UC Berkeley.
Rt. Hon. Helen Clark
Former Prime Minister, New Zealand
Former Administrator, UNDP
Rt. Hon. Helen Clark
Helen served two terms as Administrator of the United Nations Development Programme (UNDP) and as Chair of the United Nations Development Group from 2009-2017.
Earlier, Helen taught in the Political Studies Department of the University of Auckland, from which she had graduated with BA and MA (Hons) degrees.
Helen advocates for sustainable development, climate action, gender equality and women’s leadership, peace and justice, and action on pressing global health issues. In July 2020, she was appointed by the Director-General of the World Health Organisation as Co-Chair of the Independent Panel for Pandemic Preparedness and Response. She chairs the boards of the Extractive Industries Transparency Initiative, the Partnership for Maternal, Newborn and Child Health, and other public good organisations and initiatives.
Prof. Dr. Daniela Schwarzer
Member of the Executive Board, Bertelsmann Stiftung
Prof. Dr. Daniela Schwarzer
She taught at Harvard University as a visiting professor, was director of the Europe Research Group at the German Institute for International and Security Affairs (SWP), and was a board member of the German Marshall Fund of the United States.
Dr. Magda Robalo
Co-Chair, UHC2030 Steering Committee
Dr. Magda Robalo
She spearheaded successful initiatives in her current role as President and Co-Founder of The Institute for Global Health and Development and as former Minister of Public Health, Presidential High Commissioner for the COVID-19 response in Guinea-Bissau, WHO Representative, WHO Director of Communicable Diseases and Global Managing Director of Women in Global Health.
Dr. David Reddy, PhD
Director General, IFPMA
Dr. David Reddy, PhD
David has been a Board Member of the Coalition for Epidemic Preparedness (CEPI) since 2018 and serves on the Board of Malaria No More UK.
Before joining MMV, David was a Vice President at Roche, where he held corporate responsibility for Roche’s response to the 2009/2010 influenza pandemic. In this role, he led the work to develop, communicate, and implement the company’s strategy for working with governments and the WHO on pandemic preparedness, and establishing a sustainable access program.
David holds a PhD in Cellular and Molecular Biology from the University of Auckland, New Zealand and completed a post-doctoral fellowship in molecular neurobiology at the Friedrich-Miescher Institute in Basel, Switzerland.